Latest News from: Johns Hopkins Medicine

Filters close
Newswise: Researchers Advance Efforts to Tailor Drug Delivery to Cells’ ‘Power Plants’
Released: 20-Sep-2022 10:15 AM EDT
Researchers Advance Efforts to Tailor Drug Delivery to Cells’ ‘Power Plants’
Johns Hopkins Medicine

In a study using lab-grown cells, Johns Hopkins Medicine researchers specializing in aging report they have successfully delivered a common blood pressure drug directly to the inner membrane of mitochondria, the “power plants” in the cells of humans, animals, plants and most other organisms.

Newswise: Johns Hopkins Medicine Surpasses 1.5 Million Telemedicine Visits Since Start of Pandemic
Released: 19-Sep-2022 11:00 AM EDT
Johns Hopkins Medicine Surpasses 1.5 Million Telemedicine Visits Since Start of Pandemic
Johns Hopkins Medicine

Johns Hopkins Medicine physicians and clinicians have conducted more than 1.5 million telemedicine visits with over 420,000 patients in Maryland, Washington, D.C., Florida and across the country since the start of the COVID-19 pandemic, according to the Johns Hopkins Office of Telemedicine.

Newswise: Hopkins Immunotherapy Researchers Named Fellows of the SITC Academy of Immuno-Oncology
Released: 19-Sep-2022 10:00 AM EDT
Hopkins Immunotherapy Researchers Named Fellows of the SITC Academy of Immuno-Oncology
Johns Hopkins Medicine

Drew Pardoll, M.D., Ph.D., and Suzanne Topalian, M.D., leading cancer immunotherapy investigators in the Johns Hopkins Bloomberg~Kimmel Institute for Cancer Immunotherapy and Kimmel Cancer Center, have been named by the Society for Immunotherapy of Cancer (SITC) as Fellows of the Academy of Immuno-Oncology.

Newswise: A Cut Above — Two Devices Are Teamed to Simplify, Quicken and Improve Ear Reconstruction
Released: 15-Sep-2022 10:00 AM EDT
A Cut Above — Two Devices Are Teamed to Simplify, Quicken and Improve Ear Reconstruction
Johns Hopkins Medicine

Thanks to two novel tools developed by a Johns Hopkins Medicine resident and a former resident, the traditionally difficult surgery to create a replacement ear from a patient’s rib cartilage may soon be done faster, more simply and accurately.

Newswise: Blocking an Ion Channel Improves Muscle Function and Survival in Mice with Severe Duchenne Muscular Dystrophy
Released: 13-Sep-2022 12:05 PM EDT
Blocking an Ion Channel Improves Muscle Function and Survival in Mice with Severe Duchenne Muscular Dystrophy
Johns Hopkins Medicine

Researchers at Johns Hopkins Medicine report that an experimental drug first developed to treat kidney disease prolongs survival and improves muscle function in mice genetically engineered to develop a severe form of Duchenne muscular dystrophy (DMD).

Newswise: Exercise Hormone Halts Parkinson’s Disease Symptoms in Mouse Study
Released: 12-Sep-2022 11:00 AM EDT
Exercise Hormone Halts Parkinson’s Disease Symptoms in Mouse Study
Johns Hopkins Medicine

Researchers from Johns Hopkins Medicine and the Dana Farber Cancer Institute in Boston have shown that a hormone secreted into the blood during endurance, or aerobic, exercise reduces levels of a protein linked to Parkinson’s disease and halts movement problems in mice.

Newswise: Promising Anti-Cancer Drug Also May Function as COVID-19 Antiviral Therapy
Released: 8-Sep-2022 11:00 AM EDT
Promising Anti-Cancer Drug Also May Function as COVID-19 Antiviral Therapy
Johns Hopkins Medicine

Based on findings from a new study by a Johns Hopkins Medicine-led research team, an effective means of fighting SARS-CoV-2, the virus that causes COVID-19, may be possible that circumvents the problem of waning immunity often observed when current vaccines deal with emerging COVID variants.

Newswise: Full Genetic Architecture of Ras Cancer Gene Mutations in Human Tumors Uncovered
Released: 8-Sep-2022 10:00 AM EDT
Full Genetic Architecture of Ras Cancer Gene Mutations in Human Tumors Uncovered
Johns Hopkins Medicine

Researchers at the Johns Hopkins Kimmel Cancer Center, three other cancer centers and the Johns Hopkins Bloomberg School of Public Health compiled a comprehensive genetic architecture atlas for mutant RAS genes in human cancers.

Newswise: Patient Education and Feedback to Nurses Help Improve Administration Of Clot-Busting Drugs
Released: 1-Sep-2022 9:50 AM EDT
Patient Education and Feedback to Nurses Help Improve Administration Of Clot-Busting Drugs
Johns Hopkins Medicine

Johns Hopkins Medicine study suggests strategies may prevent dangerous post-surgery condition

Newswise: Psychedelics May Lessen Fear of Death and Dying, Similar to Feelings Reported by Those Who’ve Had Near Death Experiences
Released: 24-Aug-2022 2:55 PM EDT
Psychedelics May Lessen Fear of Death and Dying, Similar to Feelings Reported by Those Who’ve Had Near Death Experiences
Johns Hopkins Medicine

In a survey study of more than 3,000 adults, Johns Hopkins Medicine researchers compared psychedelic experiences with near-death experiences that were not drug related and found notable similarities in people’s attitudes toward death.

Newswise: Preparing for Class: Johns Hopkins Children’s Center Experts Available for Interviews Related to Going Back to School
Released: 24-Aug-2022 9:00 AM EDT
Preparing for Class: Johns Hopkins Children’s Center Experts Available for Interviews Related to Going Back to School
Johns Hopkins Medicine

As we approach the time of year when students switch from vacation mode to school mode, Johns Hopkins Children’s Center experts are available for interviews on a variety of back-to-school-related topics to share advice for a smooth start to the new school year.

Newswise: Significant Boost in Rates of Type 2 Diabetes Among Children During COVID-19 Pandemic
Released: 23-Aug-2022 9:00 AM EDT
Significant Boost in Rates of Type 2 Diabetes Among Children During COVID-19 Pandemic
Johns Hopkins Medicine

In a multi-site study of medical records, researchers at Johns Hopkins Children’s Center and across the United States say they have documented a steep rise in type 2 diabetes among children during the COVID-19 pandemic.

Newswise: Scientists Thought They Knew How the Nose ‘Knows,’ New Research Suggests Otherwise
Released: 18-Aug-2022 10:25 AM EDT
Scientists Thought They Knew How the Nose ‘Knows,’ New Research Suggests Otherwise
Johns Hopkins Medicine

Johns Hopkins Medicine researchers say they have evidence to potentially overturn a prevailing belief in a type of important signaling within cells. The mainstream idea is that a single protein receptor molecule — a kind of flag on the cell surface — spurs the activity of up to hundreds of downstream protein molecules to produce a signal.

Newswise: Eye Doctors Who Get Even Small Payments from Drug Companies More Likely to Prescribe Name-Brand Eyedrops
Released: 15-Aug-2022 11:00 AM EDT
Eye Doctors Who Get Even Small Payments from Drug Companies More Likely to Prescribe Name-Brand Eyedrops
Johns Hopkins Medicine

In a lookback study of prescribing patterns among thousands of American ophthalmologists and optometrists, Johns Hopkins Medicine researchers concluded that eye doctors who receive even small financial incentives from pharmaceutical companies, such as free food, sponsored travel to attend meetings or consulting fees, are up to twice as likely to prescribe the companies’ brand name eyedrops for glaucoma instead of cheaper generic versions.

Newswise: Nanoparticle Therapy May Help Patients Hospitalized with Severe COVID-19 Infections
Released: 11-Aug-2022 12:05 PM EDT
Nanoparticle Therapy May Help Patients Hospitalized with Severe COVID-19 Infections
Johns Hopkins Medicine

Johns Hopkins Medicine researchers say that an experimental dendrimer nanoparticle treatment called OP-101 substantially reduced the risk of death and need for a ventilator in a study of 24 severely ill adults hospitalized with COVID-19.

Newswise: Johns Hopkins Researchers Find Link Between Dementia and Atrial Cardiopathy
Released: 10-Aug-2022 3:25 PM EDT
Johns Hopkins Researchers Find Link Between Dementia and Atrial Cardiopathy
Johns Hopkins Medicine

Older adults with atrial cardiopathy (a major, often undetected cardiac cause of stroke) may be at increased risk of developing dementia, according to new research led by Johns Hopkins Medicine.

Newswise: Study Finds Genetic Method for Identifying Hundreds of Disease Agents ‘Promising’
Released: 9-Aug-2022 10:00 AM EDT
Study Finds Genetic Method for Identifying Hundreds of Disease Agents ‘Promising’
Johns Hopkins Medicine

In the pursuit of accurate diagnoses for illnesses, doctors have traditionally used multiple methods to try to identify the bacterium, virus, fungus or other pathogen responsible for an infection.

Newswise: Scientists Identify Novel Molecular Biomarkers in Cells That Spread a Deadly Form of Breast Cancer
Released: 8-Aug-2022 10:00 AM EDT
Scientists Identify Novel Molecular Biomarkers in Cells That Spread a Deadly Form of Breast Cancer
Johns Hopkins Medicine

Studying a deadly type of breast cancer called triple negative, Johns Hopkins Medicine scientists say they have identified key molecular differences between cancer cells that cling to an initial tumor and those that venture off to form distant tumors.

Newswise: Johns Hopkins Medicine-Led Consortium to Receive Up to $200 Million to Fight TB Globally
Released: 4-Aug-2022 11:00 AM EDT
Johns Hopkins Medicine-Led Consortium to Receive Up to $200 Million to Fight TB Globally
Johns Hopkins Medicine

To address the global burden of tuberculosis (TB), one of humankind’s oldest scourges, an international collaboration led by Johns Hopkins Medicine has today been awarded up to $200 million in research funding over five years by the U.S. Agency for International Development (USAID) Supporting, Mobilizing and Accelerating Research for Tuberculosis Elimination (SMART4TB) project.

Newswise: Early Physical Therapy Associated with Less Health Care Resource Use for Patients with Acute Lower Back Pain
Released: 2-Aug-2022 12:05 PM EDT
Early Physical Therapy Associated with Less Health Care Resource Use for Patients with Acute Lower Back Pain
Johns Hopkins Medicine

Early initiation of physical therapy (PT) for U.S. patients with acute lower back pain (LBP) was associated with less health care resource use in the first month and the first year after the initial onset of symptoms, according to a new study by Johns Hopkins Medicine.

Newswise: Johns Hopkins Medicine Scientists Create Nanobody That Can Punch Through Tough Brain Cells and Potentially Treat Parkinson’s Disease
Released: 28-Jul-2022 9:00 AM EDT
Johns Hopkins Medicine Scientists Create Nanobody That Can Punch Through Tough Brain Cells and Potentially Treat Parkinson’s Disease
Johns Hopkins Medicine

Johns Hopkins Medicine researchers have helped develop a nanobody capable of getting through the tough exterior of brain cells and untangling misshapen proteins that lead to Parkinson’s disease, Lewy body dementia, and other neurocognitive disorders caused by the damaging protein.

Newswise: Study Shows Widespread Mislabeling of CBD Content Occurs for Over-the-Counter Products
Released: 20-Jul-2022 11:15 AM EDT
Study Shows Widespread Mislabeling of CBD Content Occurs for Over-the-Counter Products
Johns Hopkins Medicine

In a new study, Johns Hopkins Medicine researchers tested more than 100 topical cannabidiol (CBD) products available online and at retail stores, and found significant evidence of inaccurate and misleading labeling of CBD content.

Newswise: Protein Parts Must Indeed Wiggle and Jiggle to Work Right, New Research Suggests
14-Jul-2022 11:00 AM EDT
Protein Parts Must Indeed Wiggle and Jiggle to Work Right, New Research Suggests
Johns Hopkins Medicine

Johns Hopkins Medicine scientists report they have probed the atomic structure of proteins to add to evidence that the wobbles, shakes and quivers of proteins play a critical role in their ability to function. The findings of the research may help scientists design new drugs that can modify or disrupt the intricate “dances” of proteins to alter their functions.

Newswise: Risk Factors in Adults with Cardiovascular Disease are Worsening Over Time Despite Advances in Secondary Prevention, Study Shows
Released: 14-Jul-2022 10:00 AM EDT
Risk Factors in Adults with Cardiovascular Disease are Worsening Over Time Despite Advances in Secondary Prevention, Study Shows
Johns Hopkins Medicine

In an analysis of medical information of more than 6,000 American adults with a history of cardiovascular disease (CVD), researchers at Johns Hopkins Medicine conclude that CVD risk “profiles” in secondary prevention have failed to improve over the last two decades.

Newswise: Study Suggests That C. Difficile Drives Some Colorectal Cancers
Released: 14-Jul-2022 10:00 AM EDT
Study Suggests That C. Difficile Drives Some Colorectal Cancers
Johns Hopkins Medicine

Data collected by researchers at the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy suggest that Clostridioides difficile, or C. diff, a bacterial species well known for causing serious diarrheal infections, may also drive colorectal cancer.

Newswise: Duration of Preoperative Pain Linked to Chronic Opioid Use After Adult Spinal Deformity Surgery
Released: 13-Jul-2022 11:00 AM EDT
Duration of Preoperative Pain Linked to Chronic Opioid Use After Adult Spinal Deformity Surgery
Johns Hopkins Medicine

In a Johns Hopkins Medicine study of patients who underwent adult spinal deformity (ASD) surgery, preoperative opioid use and pain duration of four or more years were independently associated with higher odds of chronic post-surgery opioid use.

Newswise: Regular Screening Of People At High Risk For Pancreatic Cancer Pays Off
Released: 13-Jul-2022 10:00 AM EDT
Regular Screening Of People At High Risk For Pancreatic Cancer Pays Off
Johns Hopkins Medicine

Surveillance programs for people at high risk of developing pancreatic cancers can help detect precancerous conditions and cancers early, when they are most treatable, according to a new multicenter study directed by experts at the Johns Hopkins Kimmel Cancer Center.

Newswise: Johns Hopkins Medicine Study: Abnormal Heart Metabolism May Predict Future Sudden Cardiac Death
Released: 11-Jul-2022 11:00 AM EDT
Johns Hopkins Medicine Study: Abnormal Heart Metabolism May Predict Future Sudden Cardiac Death
Johns Hopkins Medicine

Adults with abnormal heart metabolism are up to three times more likely to experience life-threatening arrhythmias (an irregular heart rhythm), and MRI techniques could be used to detect the condition and predict future sudden cardiac death (SCD), according to a small, but rigorous study led by Johns Hopkins Medicine researchers.

Newswise: Johns Hopkins Researchers Call for Closing Gap in Collecting Racial and Ethnic Data in Studies of Rare Genetic Condition
Released: 11-Jul-2022 9:00 AM EDT
Johns Hopkins Researchers Call for Closing Gap in Collecting Racial and Ethnic Data in Studies of Rare Genetic Condition
Johns Hopkins Medicine

In a review of published research papers, investigators from the Johns Hopkins Medicine Hereditary Hemorrhagic Telangiectasia (HHT) Center have identified a substantial lack of racial and ethnic data that may be negatively impacting the treatment and diagnosis of this rare disorder in diverse patients.

Newswise: Stay Safe All Summer Long
Released: 29-Jun-2022 11:00 AM EDT
Stay Safe All Summer Long
Johns Hopkins Medicine

As school ends, summer fun begins. Johns Hopkins Children’s Center experts say safety is the key to an enjoyable season for the whole family. Children’s Center experts are available to provide some top tips for the months ahead.



close
0.26693